Cambridge [UK], March 25 (ANI/Sputnik): UK-Swedish drugmaker AstraZeneca on Thursday reasserted effectiveness of its vaccine after recalculating data from the disputed US study, albeit revising its efficacy in preventing symptomatic coronavirus cases down by three percentage points to 76 per
Hyderabad (Telangana) [India], January 12 (ANI): Dr Reddy's Laboratories has said that independent Data and Safety Monitoring Board (DSMB) reviewed the safety data from phase two clinical trial of Russia's Covid-19 vaccine Sputnik V and recommended phase three recruitment along with continui
New Delhi [India], September 16 (ANI): The Drugs Controller General of India (DCGI) has allowed Serum Institute of India (SII) to restart its phase two and three clinical trials for COVID-19 vaccine after the pharma major submitted the recommendations of the Data Safety Monitoring Board (DSM